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ABSTRACT
Chromolaena odorata is commonly known as Siam weed which belongs to sunflower family Asteraceae. C. odorata is an important medicinal plant 
which can be easily found in tropical Asia, West Africa, and parts of Australia. It is native to the America, and found in Florida and Texas in the United 
States, throughout Mexico and the Caribbean to South America. The medicinal usage of C. odorata has been reported in the traditional systems of 
medicine such as Ayurveda, Siddha, and Unani. It has wide variety of ethanomedicinal and pharmacological properties. The young leaves are crushed, 
and the resulting liquid can be used to treat skin wounds. The leaves extract is used by the kani tribals of Kouthalai in Tirunelveli hills to cure skin 
diseases, poison bites, wounds, and rheumatism. Following various folk claims for the ailment of various diseases, efforts have been made by the 
researchers to verify the efficacy of this weed through scientific biological screenings. A study of the literature revealed some notable pharmacological 
activities of the shrub such as anthelmintic, antimalarial, analgesic, anti-inflammatory, antipyretic, antispasmodic, antioxidant, antigonorrheal, 
antimycobacterial, insecticidal, fungicidal, wound healing, diuretic, blood coagulation, and antibacterial. The current review is created with an intent 
to focus on the numerous ethnobotanical and traditional uses as well as the phytochemical and pharmacological reports on C. odorata.
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INTRODUCTION
Currently, natural products are a significant source of new compounds, 
leading to the synthesis of drugs in all major disease areas. They 
epitomize a pool of structures that have been optimized by evolution 
to interact with different molecules such as proteins and other 
molecules [1]. The starting materials for about one-half of the medicines 
we use today come from natural sources. The future of higher plants as 
sources of medicinal agents for use in investigation, prevention, cure, 
and treatment of diseases is also very promising [2]. During the past 
decade, the traditional systems of medicine have become progressively 
popular keeping in mind their safety. Natural products proved to be 
an important source of lead compounds in the development of new 
drugs [3]. Natural products have provided some of the important 
lifesaving drugs used in the armamentarium of modern medicine. 
However, among the estimated 250,000–400,000 plant species, only 6% 
have been studied for biological activity and 15% have been examined 
phytochemically [4]. Phytochemicals may protect human from a variety 
of diseases. Phytochemicals are non-nutritive plant compounds, which 
have protective, curative, or disease preventive properties. Plants 
produce these chemicals to protect themselves, but recent research 
demonstrates that many phytochemicals can protect humans against 
diseases. There are many phytochemicals in fruits and herbs and each 
works differently [5]. This illustrates the need for planned activity 
guided phytopharmacological evaluation of herbal drugs. This article 
aims to provide an overview of the chemical constituents present 
in various parts of Chromolaena odorata and their ethnobotanical 
and pharmacological actions. It has been claimed in Ayurveda that 
C. odorata possesses proven medicinal properties and is the ingredient 
of many formulations.
HABITAT AND DISTRIBUTION
The family Asteraceae comprises over 165 species that are distributed 
across tropical and subtropical regions. The tropical and subtropical 
regions are the best for growth of Siam weed, and though not tolerant of 
cold climate it can be still found at altitudes up to 1000 m. Even though 
Siam weed grows on most soil types, it preferred well-drained soils in 
full sun. It has a viable benefit over other plants in weathers with distinct 
wet and dry seasons because it endures fires and grows back vigorously 
following rain. It is one of the invasive, fast-growing plants, and thrives 
in disturbed areas such as meadows, farms, clearings, roadsides, and 
shores, particularly those in well-lit sites. Siam weed is misleadingly 
named as it is actually a native of Central and Northern South America, 
from Mexico to Brazil. Although first introduced into India as an 
ornamental, it has quickly spread throughout its current range [6].
MORPHOLOGY
C. odorata or Siam weed has a minimum 10-year life span. It is a rapidly 
growing perennial herb. Siam weed is a big bushy herb or subshrub with 
long rambling but not having twisted branches. In open areas, it spreads 
into scrambled and compressed thickets up to 2-meter high. The main 
stem consists of many paired branches. The base of the plant becomes 
hard and woody. Branch tips are often soft and green. The arrowhead-
shaped leaves have three characteristic veins in a “pitchfork” pattern. 
Leaves are 4–10 cm long and 1–5 cm wide. They breed in contradictory 
pairs alongside the stems and branches. The term “Odorata” suggests 
that the leaves release a pungent, aromatic odor when crushed. Light 
pink-mauve or white tubular flowers, 10 mm long, are found at the ends 
of branches in clusters of 10–35. The dark-colored seeds are 4–5 mm 
long, narrow, and oblong, with a parachute of white hairs which turn 
brown as the seed dries. 80,000–90,000 seeds are produced per 
plant. Siam weed is native to tropical America but is now acclimatized 
throughout the tropics [7]. Habit (a), flowers (b), leaves (c), and seeds 
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C. odorata aka Eupatorium odoratum is a weedy herb native of Central 
and South America, which has spread throughout the tropical and 
subtropical areas [9,10]. It was first introduced to Southeast Asia in the 
1920s and Africa in around 1940 as a plantation cover crop and has 
ever since spread worldwide (Table 1) [11,12].
Phytoconstituents
The dried leaf of C. odorata contained carbohydrate (31%), crude 
protein (18%), fiber (15%), crude fat (11%), ash (11%), and moisture 
(15%) [14]. Its active phytochemical substances are as follows:
1. Essential oils [15-17].
2. Flavonoid aglycones (flavanones, flavonols, and flavones) including 
naringenin, kaempferol, quercetin, acacetin, chalcones, eupatilin, 
luteolin, quercetagetin, and sinensetin [18-21].
3. Terpenes and terpenoids [22].
4. Saponins and tannins [14].
Some major phytoconstituents are shown in Fig. 2.
5. Alkaloids including pyrrolizidine [23-25].
6. Phytoprostane compound including chromomoric acid [26].
7. Phenolic acids including ferulic acid and protocatechuic acid [27].
Traditional uses
From literature review regarding the traditional uses, phytochemical 
properties of C. odorata are antibacterial [28-31], anticancer [32], 
anticonvulsant [33], antidiabetic [34-36], antidiarrheal [37,38], 
antifungal [39,40], anti-inflammatory [41-43], antioxidant [44-47], 
and antiparasitic [24], hemostatic and wound healing [47,48], and 
hepatoprotective activities [49,50].
PHARMACOLOGICAL ACTIVITIES
C. odorata is found to be a highly efficient medicinal herb according to 
the traditional and widespread medicinal systems. The same is proved 
by its pharmacological evaluation performed by scientific community 
across the world.
Anti-inflammatory, analgesic, and antipyretic activity
C. odorata is traditionally usage in the treatment of rheumatic fever 
and similar conditions. This is evident for anti-inflammatory, analgesic, 
and antipyretic activities of the C. odorata. In the study conducted 
by Umukoro et al., 2006, for pharmacological evaluation of the drug 
extract in different animal experimental models which comprise 
carrageenan paw edema and cotton pellet granuloma for determination 
of anti-inflammatory activities, hot plate, and formalin paw licking tests 
for determination of analgesic activities, and Brewer’s yeast induced 
pyrexia for determination of antipyretic tests.
The result shows that the extract produced dose-dependent anti-
inflammatory, analgesic, and antipyretic activities. Other studies have 
shown that the anti-inflammatory activity may be attributed because of 
the presence of flavonoids in the extract [51,52].
Antimicrobial activity
The C. odorata plant considered and used traditionally for its 
antimicrobial action, thus the antimicrobial activity of was evaluated in 
multiple experiments by various researchers.
This antimicrobial activity plays a major role in the aspect of wound 
healing power, which is expressed by the shrub. The C. odorata 
dichloromethanolic and ethanolic crude extracts have been assessed 
against 22 strains of microorganisms consisting of various Gram-
positive and Gram-negative bacteria and yeasts.
Pisutthanan et al., 2005, presented that all crude extracts have shown 
activity, mainly against Gram-positive bacteria. The extracts have also 
shown modest activity against Mycobacterium tuberculosis [52]. The 
dichloromethane-water extract of the plant exhibited significant anti-
herpes simplex virus-1 and antimalarial activity [52]. Ling et al. found 
out that the activity is particularly stronger against staphylococci [53]. 
The extract also displayed appreciable antifungal activity [54]. Thoden 
et al., 2007, have also demonstrated profound nematicidal activity of 
the herb [24].
Antioxidant
The profound antioxidant action of the plant is the basis of its external 
application of C. odorata [51,53]. Phan et al., 2001, assessed the plant 
extract for its antioxidant effects using purified fractions on cultured 
fibroblasts and keratinocytes. This experiment was evaluated by 
investigation with the help of colorimetric and lactate hydrogenase 
release assay.
The results of this test indicated that the phenolic acids, which are 
present in the extract such as p-coumaric, ferulic, protocatechuic, 
p-hydroxybenzoic, and vanillic acids, as well as complex mixtures 
of hydrophobic flavonoid aglycones such as flavones, flavanones, 
chalcones, and flavonols, were principal and potent antioxidants [27].
Table 1: Names used worldwide of C. odorata are as 
follows [12,13]
Language Vernacular name
English Devil weed, Christmas bush, Jack in the bush, 
communist weed, Siam weed
Hindi Bagh dhoka, tivra gandha
French Herbe du Laos
German Siam kraut
Guam Kesengesil
African Sekou toure, acheampong, jabinde, matapa, 
mighbe
Indonesian Rumput belalang, rumput putih, rumput golkar
Malayalam Pokok kapal terbang, rumput jepun, rumput 
Siam
Sanskrit Ropani, seekhrasarpi
Spanish Cariaquillo Santa Maria
Tagalog Agonoi, hagonoy, huluhagonoi
Thai Sab suea
Vietnamese Co hoi
C. odorata: Chromolaena odorata
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The nitric oxide scavenging activity of the C. odorata extract was 
demonstrated by Alisi et al., 2008, in which it was quantitatively 
determined by the total phenolic content which shows that the extract 
contains an appreciable quantity of the phenolic compounds and these 
compounds might be responsible for the antioxidant potential of the 
extract [55].
Cardiovascular effects
The studies conducted by Umukoro et al., 2006, on the cardiovascular 
effects of the C. odorata extract exhibited its significant membrane 
stabilizing activity against hemolysis as well as PAF receptor-binding 
inhibiting property [51].
Cytoprotective
An experiment conducted by Nurjannah et al., 2006, in rats proved their 
efficacy as an antiulcer agent when used orally [56]. For this research, C. 
odorata extract was given in combination with honey for its use in the 
treatment of stomach ulcer lacerations. Cytotoxic studies of the C. odorata 
extract were also carried out. These studies demonstrated the presence 
of number of compounds in the extract such as acacetin (5, 7-dihydroxy-
4’-methoxy flavone) and luteolin (5, 7, 3’, 4’-tetrahydroxyflavone). These 
compounds also expressed for their significant activity against human 
small cell lung cancer and human breast cancer.
Wound healing
The most established and discussed aspect of Chromolaena is its role 
in wound healing. Ayyanar et al., 2009, established that extracts from 
the leaves of C. odorata have been shown to be useful for the treatment 
of wounds. In traditional usage, the leaf is ground into a paste and is 
applied topically on affected places to heal wounds [57]. Raina et al., 
2008, showed that the aqueous extract and the decoction from leaves of 
this plant have been used throughout Vietnam for the treatment of soft 
tissue wounds and burns for decades. A product named EUPOLIN made 
from Chromolaena has already been licensed for use in Vietnam for soft 
tissue burns and injuries [58,59].
CONCLUSION
C. odorata is very useful habit for treating various types of diseases. 
Various studies have demonstrated that C. odorata possesses anti-
inflammatory, analgesic, antipyretic, antimicrobial, cardiovascular 
effects, cytoprotective, wound healing, nematicidal, and antimalarial 
activity. The chemical constituents such as phenolic acids, flavonoids, 
and other important chemical constituents are responsible for 
these activities. Review of the literature concluded that C. odorata is 
considered to be a useful herbal medicinal plant.
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